L Trademark

Trademark Overview


On Thursday, June 6, 2024, a trademark application was filed for L with the United States Patent and Trademark Office. The USPTO has given the L trademark a serial number of 98587950. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, December 31, 2024. This trademark is owned by Lymphoma Research Foundation. The L trademark is filed in the Advertising, Business and Retail Services category with the following description:

Promoting Public Awareness Of The Need For Research And Treatment In The Field Of Lymphoma
l

General Information


Serial Number98587950
Word MarkL
Filing DateThursday, June 6, 2024
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, December 31, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 21, 2025

Trademark Statements


Description of MarkThe mark consists of a stylized "L".
Pseudo MarkLYMPHOMA
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPromoting Public Awareness Of The Need For Research And Treatment In The Field Of Lymphoma

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, June 6, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLymphoma Research Foundation
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew York, NY 10006

Trademark Events


Event DateEvent Description
Thursday, June 6, 2024NEW APPLICATION ENTERED
Wednesday, December 18, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 27, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 15, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 19, 2024ASSIGNED TO EXAMINER